Freestone Capital Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-258,421	Closed	-$5.57M	–	454
2018 Q3	$5.57M	Sell	258,421 -7,293	-3%	-$169K	0.04%	94
2018 Q2	$6.46M	Buy	265,714 +23,410	+10%	+$477K	0.04%	84
2018 Q1	$4.14M	Buy	242,304 +129,176	+114%	+$2.52M	0.24%	111
2017 Q4	$2.14M	Sell	113,128 -32,584	-22%	-$490K	0.15%	145
2017 Q3	$2.56M	Buy	145,712 +37,583	+35%	+$846K	0.18%	129
2017 Q2	$3.59M	Buy	108,129 +16,899	+19%	+$523K	0.28%	98
2017 Q1	$2.93M	Buy	91,230 +48,403	+113%	+$1.65M	0.23%	120
2016 Q4	$1.55M	Sell	42,827 -53,945	-56%	-$2.15M	0.13%	152
2016 Q3	$4.45M	Buy	96,772 +11,341	+13%	+$592K	0.41%	50
2016 Q2	$4.29M	Buy	85,431 +17,624	+26%	+$938K	0.42%	49
2016 Q1	$3.63M	Buy	67,807 +14,387	+27%	+$844K	0.38%	48
2015 Q4	$3.51M	Buy	53,420 +14,978	+39%	+$926K	0.36%	43
2015 Q3	$2.17M	Buy	38,442 +25,201	+190%	+$1.63M	0.24%	64
2015 Q2	$783K	Buy	+13,241	New	+$817K	0.12%	128
2014 Q2	–	Sell	-6,904	Closed	-$365K	–	253
2014 Q1	$365K	Sell	6,904 -6,229	-47%	-$288K	0.06%	151
2013 Q4	$527K	Buy	13,133 +5,088	+63%	+$200K	0.09%	185
2013 Q3	$304K	Sell	8,045 -337	-4%	-$13.1K	0.05%	278
2013 Q2	$329K	Buy	+8,382	New	+$326K	0.07%	241